Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma

BACKGROUND: This study aimed to compare the feasibility of nab‐paclitaxel plus platinum‐based chemotherapy (nabTP) versus paclitaxel plus platinum‐based chemotherapy (TP) with immune checkpoint inhibitors (ICIs) as a neoadjuvant modality for locally resectable esophageal squamous cell carcinoma (ESC...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yafan, Li, Haomiao, Chen, Xiankai, Qin, Jianjun, Li, Yong, Shen, Yaxing, Zhang, Ruixiang, Kang, Xiaozheng, Wang, Zhen, Zheng, Qingfeng, Luo, Peng, Li, Yin, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981310/
https://www.ncbi.nlm.nih.gov/pubmed/36788648
http://dx.doi.org/10.1111/1759-7714.14795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981310/
https://www.ncbi.nlm.nih.gov/pubmed/36788648
http://dx.doi.org/10.1111/1759-7714.14795

Ejemplares similares